Device Wound Closure

Dermabond

Payments companies reported to CMS as associated with Dermabond. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.4Massociated payments (2023-2025)

2,611clinicians with associated payments

9companies reporting

By year

2023 $702K

2024 $772K

2025 $940K

Payments reported as associated with Dermabond, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Physician Assistant $577K

Orthopaedic Surgery $327K

Surgical $321K

Adult Reconstructive Orthopaedic Surgery $215K

Neurological Surgery $210K

Otolaryngology $119K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dermabond

These are the largest totals companies reported as associated with Dermabond. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Steven Wurzelbacher	Cincinnati, OH	Physician Assistant	$152,855.34
Antonia Chen	Dallas, TX	Adult Reconstructive Orthopaedic Surgery	$151,254.55
Heather Austin	Salinas, CA	Physician Assistant	$140,387.18
Dennis Kraus	New York, NY	Otolaryngology	$117,435.00
Sean Rajaee	West Hollywood, CA	Orthopaedic Surgery	$117,294.06
Suken Shah	Wilmington, DE	Orthopaedic Surgery	$116,251.05
Michael Wang	Miami, FL	Neurological Surgery	$101,260.00
Joshua Beardsley	Rock Hill, SC	Surgical	$99,782.43
Christopher Ducoin	Tampa, FL	Surgery	$88,521.86
Jeanine Gargiulo	Alexandria, VA	Surgical	$88,236.15

Prescribed Dermabond?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.